Renske MT ten Ham Read more about Renske MT ten Ham health economics health technology assessment cost of gene therapies Cell Therapy Regenerative Medicine
The global politics of human embryonic stem cell science: Regenerative medicine in transition Read more about The global politics of human embryonic stem cell science: Regenerative medicine in transition
The dangers of cloning and the promise of regenerative medicine Read more about The dangers of cloning and the promise of regenerative medicine
Science: Stem cells and regenerative medicine Read more about Science: Stem cells and regenerative medicine
Stem cells and the future of regenerative medicine, by the Board on Life Sciences, National Research Council, and Board on Neuroscience and Behavioral Health, Institute of Medicine Read more about Stem cells and the future of regenerative medicine, by the Board on Life Sciences, National Research Council, and Board on Neuroscience and Behavioral Health, Institute of Medicine
The commercialization of human stem cells: Ethical and policy issues Read more about The commercialization of human stem cells: Ethical and policy issues
Harnessing and sharing the benefits of state-sponsored research: Intellectual property rights and data sharing in California's stem cell initiative Read more about Harnessing and sharing the benefits of state-sponsored research: Intellectual property rights and data sharing in California's stem cell initiative
The dawn of genomic and regenerative medicine: New paradigms for medicine, the public's health, and society Read more about The dawn of genomic and regenerative medicine: New paradigms for medicine, the public's health, and society
Protecting methods for treatment related to regenerative medicine and gene therapy in Japan Read more about Protecting methods for treatment related to regenerative medicine and gene therapy in Japan
Regenerative medicine: Stem cells and the science of monstrosity Read more about Regenerative medicine: Stem cells and the science of monstrosity
